Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RELUGOLIX vs REPAGLINIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RELUGOLIX vs REPAGLINIDE: Safety Overview

Metric RELUGOLIX REPAGLINIDE
Total FAERS Reports 20,660 2,544
Deaths Reported 958 169
Death Rate 4.6% 6.6%
Hospitalizations 1,699 1,517
Average Patient Age 72.4 yrs 71.9 yrs
% Female Patients 1.4% 45.5%
FDA Approval Date Dec 18, 2020 Apr 24, 2015
Manufacturer Sumitomo Pharma America, Inc. Rising Pharma Holdings, Inc.
Route ORAL ORAL
Marketing Status Prescription Discontinued